Steven Boyd seems to agree. Armistice Capital, the hedge fund he founded in July 2012, finds value in smaller companies that are neglected by other managers. "A lot of hedge funds think sub-$1 billion companies are too small to care about," says Boyd, "but that's where we find the most opportunities." Heatmaps of the top 20 holdings and a list of the largest trades made by Armistice Capital, the hedge fund managed by Steven Boyd. Nov 14, 2019 · Armistice Capital - Steven Boyd assets under management (13F Holdings), latest news, 13D/G filings, and investor letters provided by Insider Monkey Toggle navigation Markets Apr 16, 2019 · Mr. Boyd is the Founder and Chief Investment Officer of Armistice Capital, a healthcare equity hedge fund he has built to over $800M in assets under management since Armistice's founding in 2012.
Steven Boyd – 5,292,308 (iii) Sole power to dispose or to direct the disposition of . Armistice Capital, LLC – 0. Armistice Capital Master Fund Ltd. – 0. Steven Boyd – 0 (iv) Shared power to dispose or to direct the disposition of . Armistice Capital, LLC – 5,292,308. Armistice Capital Master Fund Ltd. – 5,292,308. Steven Boyd ... Steven J. Boyd is affiliated with Armistice Capital LLC, York Capital Management Global Advisors LLC, Senator Investment Group LP, SAB Capital Management, McKinsey & Co., Inc. Stay informed and up-to-date on your network with RelSci news and business alerting service. Dec 27, 2019 · Armistice Capital, managed by Steven Boyd, assembled the biggest position in The Kraft Heinz Company (NASDAQ:KHC). Armistice Capital had $41.9 million invested in the company at the end of the ... Join LinkedIn Summary. Mr. Steven Boyd, Principal. Prior to forming Halyard, Mr. Boyd was a Managing Director of Fixed Income and Risk Management at Sterling Stamos.
Jun 24, 2019 · Steven Boyd, Chief Investment Officer, founded Armistice Capital in 2012. Steven was the first analyst at Senator Investment Group in 2008, joining the firm with its founders from York Capital. Armistice was the winner of 2017 US Hedge Fund Performance Awards by HFM for long/short equity, long/short equity long-term performance (5 years) under ... Apr 16, 2019 · Mr. Boyd is the Founder and Chief Investment Officer of Armistice Capital, a healthcare equity hedge fund he has built to over $800M in assets under management since Armistice's founding in 2012.
Dec 03, 2018 · Steven Boyd, Founder and Chief Investment Officer of Armistice Capital, is expected to be appointed to the board of directors at an upcoming board meeting in the first calendar quarter of 2019. Josh Disbrow, Aytu BioScience's Chief Executive Officer, commented, "We look forward to having Steve Boyd and Ketan Mehta on Aytu BioScience's board of ... Top 10 Stocks Held By Armistice Capital LLC By Holdings Channel Staff, updated Friday, January 10, 5:17 PM
Nov 14, 2019 · Armistice Capital - Steven Boyd assets under management (13F Holdings), latest news, 13D/G filings, and investor letters provided by Insider Monkey Toggle navigation Markets Armistice Capital, LLC Armistice Capital Master Fund Ltd. Steven Boyd (b). Address of Principal Business Office, or if None, Residence: Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, New York 10022 United States of America Armistice Capital Master Fund Ltd. c/o dms Corporate Services Ltd. 20 ... Nov 06, 2019 · Steven Boyd , CIO Steven Boyd is the Founder and Managing Partner of Armistice . Prior to Armistice, Steven was a Senior Research Analyst at Senator Investment Group since pre-launch (February 2008). Before Senator, he was an Associate at York Capital , focusing primarily on investments in consumer and health care equities.
Nov 09, 2019 · Armistice Capital, LLC is a New York Foreign Limited-Liability Company filed on June 4, 2012. The company's filing status is listed as Active and its File Number is 4253417 . The Registered Agent on file for this company is Armistice Capital, LLC and is located at Attn: Steven Boyd 510 Madison Ave, 7th Floor, New York, NY 10022. Oct 28, 2019 · Steven is the Chief Investment Officer of Armistice Capital, a long-short equity hedge fund focused on the health care and consumer sectors based in New York City. Previously, Mr. Boyd had been a Research Analyst at Senator Investment Group , York Capital , and SAB Capital Management , where he focused on health care. Mr. Boyd began his career ... Apr 12, 2016 · Boyd runs Armistice Capital, which has had an annualized return of 24% since 2012. He argued on the Halftime Report that while there's been a sell-off, the fundamentals have not actually changed ... Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
A hedge fund or institutional investor must file a Schedule 13D or 13G with the SEC when they acquire beneficial ownership of more than 5% of any class of a company’s equity securities.